|
Tags: Replaced Manual revert |
| (109 intermediate revisions by 62 users not shown) |
| Line 1: |
Line 1: |
| {{DISPLAYTITLE:}}
| | %About_Yourself% |
| __NOTOC__
| |
| <!-- Hides title of Main Page via CSS (see PART B) -->
| |
| | |
| <div class="neoplasm-center">
| |
| <div class="neoplasm-hero-title">'''HemOnc.org - A Human-Curated Hematology/Oncology Reference'''</div>
| |
| </div>
| |
| | |
| <div class="neoplasm-center neoplasm-hero-subtitle">
| |
| HemOnc.org is the largest freely available medical wiki of [[:Category:Intervention_index|interventions]], [[:Category:Regimen_index|regimens]], and [[:Category:General_reference_pages|general information]] relevant to the fields of hematology and oncology. Any healthcare professional can [[How to contribute|sign up to contribute]]; the [[Eligibility criteria|accuracy and completeness of content]] is overseen by the [[Editorial Board]]. If this is your first time visiting, please start with the '''[[Tutorial|the tutorial page]]''', review our '''[[philosophy]]''', or just start exploring!
| |
| </div>
| |
| | |
| {| class="wikitable neoplasm-table neoplasm-table--stats"
| |
| |-
| |
| | colspan="4" class="neoplasm-table-title" | Content overview as of December 17, 2025
| |
| |-
| |
| ! class="neoplasm-stat" | [[Tutorial#Regimens|Regimens]]: 5,652
| |
| ! class="neoplasm-stat" | [[Guidelines|Guidelines]]: 1,204
| |
| ! class="neoplasm-stat" | Studies: 7,228
| |
| ! class="neoplasm-stat" | References: 10,377
| |
| |}
| |
| | |
| {| class="wikitable neoplasm-table neoplasm-table--quicklinks"
| |
| |-
| |
| | colspan="5" class="neoplasm-table-title" | Quick links to major topic areas
| |
| |-
| |
| | class="neoplasm-chip neoplasm-chip--solid" | [[#solidtumors|Solid Tumors]]
| |
| | class="neoplasm-chip neoplasm-chip--malignant" | [[#malignantheme|Malignant Hematology]]
| |
| | class="neoplasm-chip neoplasm-chip--peds" | [[#peds|Pediatrics]]
| |
| | class="neoplasm-chip neoplasm-chip--tx" | [[#transplant|Transplant & IEC]]
| |
| | class="neoplasm-chip neoplasm-chip--classical" | [[#classicalheme|Classical Hematology]]
| |
| |}
| |
| | |
| ==Links to all main disease pages==
| |
| <span id="solidtumors"></span>
| |
| | |
| {| class="wikitable neoplasm-table neoplasm-table--grid"
| |
| |-
| |
| ! colspan="4" class="neoplasm-major neoplasm-major--solid" | '''Solid Tumors'''
| |
| |-
| |
| | colspan="4" class="neoplasm-minor neoplasm-minor--solid" | '''Breast Oncology'''
| |
| |-
| |
| | colspan="4" class="neoplasm-sub" | '''Early breast cancer (EBC)'''
| |
| |-
| |
| | class="neoplasm-cell" | [[Early breast cancer|EBC, NOS]]
| |
| | class="neoplasm-cell" | [[Early breast cancer, HR-positive|HR-positive EBC]]
| |
| | class="neoplasm-cell" | [[Early breast cancer, HER2-positive|HER2-positive EBC]]
| |
| | class="neoplasm-cell" | [[Early breast cancer, HER2-low|HER2-low EBC]]
| |
| |-
| |
| | class="neoplasm-cell" | [[Early breast cancer, HR and HER2 co-expressing|HR-positive and HER2-positive EBC]]
| |
| | class="neoplasm-cell" | [[Early breast cancer, triple negative|Early triple-negative breast cancer (eTNBC)]]
| |
| |-
| |
| | colspan="4" class="neoplasm-sub" | '''Metastatic breast cancer (MBC)'''
| |
| |-
| |
| | class="neoplasm-cell" | [[Metastatic breast cancer|MBC, NOS]]
| |
| | class="neoplasm-cell" | [[Metastatic breast cancer, HR-positive|HR-positive MBC]]
| |
| | class="neoplasm-cell" | [[Metastatic breast cancer, HER2-positive|HER2-positive MBC]]
| |
| | class="neoplasm-cell" | [[Metastatic breast cancer, HER2-low|HER2-low MBC]]
| |
| |-
| |
| | class="neoplasm-cell" | [[Metastatic breast cancer, HR and HER2 co-expressing|HR-positive and HER2-positive MBC]]
| |
| | class="neoplasm-cell" | [[Metastatic breast cancer, triple negative|Metastatic triple-negative breast cancer (mTNBC)]]
| |
| | class="neoplasm-cell" | [[Breast cancer, CNS metastases|CNS metastases]]
| |
| |-
| |
| | colspan="4" class="neoplasm-sub" | '''Breast cancer with molecular alterations'''
| |
| |-
| |
| | class="neoplasm-cell" | [[Breast cancer, BRCA-mutated|BRCA-mutated Breast cancer]]
| |
| | class="neoplasm-cell" | [[Metastatic breast cancer, PI3K pathway-altered|PI3K pathway-altered Breast cancer]]
| |
| |-
| |
| | colspan="4" class="neoplasm-minor neoplasm-minor--solid" | '''Dermatologic Oncology'''
| |
| |-
| |
| | colspan="4" class="neoplasm-sub" | '''Melanoma'''
| |
| |-
| |
| | class="neoplasm-cell" | [[Melanoma|Melanoma, NOS]]
| |
| | class="neoplasm-cell" | [[Melanoma,_BRAF-mutated|BRAF-mutated Melanoma]]
| |
| | class="neoplasm-cell" | [[Melanoma,_KIT-mutated|KIT-mutated Melanoma]]
| |
| | class="neoplasm-cell" | [[Melanoma,_NRAS-mutated|NRAS-mutated Melanoma]]
| |
| |-
| |
| | class="neoplasm-cell" | [[Uveal melanoma]]
| |
| |-
| |
| | colspan="4" class="neoplasm-sub" | '''Non-melanoma skin cancer (NMSC)'''
| |
| |-
| |
| | class="neoplasm-cell" | [[Cutaneous basal cell carcinoma|Cutaneous BCC]]
| |
| | class="neoplasm-cell" | [[Cutaneous squamous cell carcinoma|Cutaneous SCC]]
| |
| | class="neoplasm-cell" | [[Merkel cell carcinoma|Merkel cell carcinoma (MCC)]]
| |
| |-
| |
| | colspan="4" class="neoplasm-minor neoplasm-minor--solid" | '''Endocrine Oncology'''
| |
| |-
| |
| | colspan="4" class="neoplasm-sub" | '''Other endocrine cancers'''
| |
| |-
| |
| | class="neoplasm-cell" | [[Adrenocortical carcinoma]]
| |
| | class="neoplasm-cell" | [[Neuroendocrine tumor|Neuroendocrine tumor (NET)]]
| |
| | class="neoplasm-cell" | [[Neuroendocrine carcinoma|Neuroendocrine carcinoma (NEC)]]
| |
| | class="neoplasm-cell" | [[Pancreatic NET]]
| |
| |-
| |
| | class="neoplasm-cell" | [[Pheochromocytoma]]
| |
| |-
| |
| | colspan="4" class="neoplasm-sub" | '''Thyroid cancer without molecular alterations'''
| |
| |-
| |
| | class="neoplasm-cell" | [[Thyroid cancer|Thyroid cancer, NOS]]
| |
| | class="neoplasm-cell" | [[Thyroid cancer, anaplastic|Anaplastic thyroid cancer (ATC)]]
| |
| | class="neoplasm-cell" | [[Thyroid cancer, differentiated|Differentiated thyroid cancer (DTC)]]
| |
| | class="neoplasm-cell" | [[Thyroid cancer, medullary|Medullary thyroid cancer (MTC)]]
| |
| |-
| |
| | colspan="4" class="neoplasm-sub" | '''Thyroid cancer with molecular alterations'''
| |
| |-
| |
| | class="neoplasm-cell" | [[Thyroid_cancer,_BRAF-mutated|BRAF-mutated Thyroid cancer]]
| |
| | class="neoplasm-cell" | [[Thyroid_cancer,_RET-positive|RET-positive Thyroid cancer]]
| |
| |-
| |
| | colspan="4" class="neoplasm-minor neoplasm-minor--solid" | '''Gastrointestinal Oncology'''
| |
| |-
| |
| | colspan="4" class="neoplasm-sub" | '''Upper GI tract'''
| |
| |-
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Esophageal cancer|Esophageal cancer, NOS]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Esophageal adenocarcinoma]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Esophageal squamous cell carcinoma|Esophageal squamous cell carcinoma (ESCC)]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Gastric cancer|Gastric cancer, NOS]]
| |
| |-
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Gastric cancer, HER2-positive|HER2-positive gastric cancer]]
| |
| |-
| |
| | colspan="4" class="neoplasm-sub" | '''Lower GI tract'''
| |
| |-
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Anal cancer]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Appendiceal tumor]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Colon cancer|Colon cancer, NOS]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Colon cancer, RAS wild-type|RAS wild-type colon cancer]]
| |
| |-
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Colorectal cancer|Colorectal cancer (CRC), NOS]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Colorectal cancer, BRAF-mutated|BRAF-mutated CRC]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Colorectal cancer, HER2-positive|HER2-positive CRC]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Colorectal cancer, MSI-H or dMMR|MSI-H or dMMR CRC]]
| |
| |-
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Colorectal cancer, RAS wild-type|RAS wild-type CRC]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Rectal cancer]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Small bowel adenocarcinoma]]
| |
| |-
| |
| | colspan="4" class="neoplasm-sub" | '''Hepatobiliary cancer'''
| |
| |-
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Biliary tract cancer]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Cholangiocarcinoma]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Gallbladder cancer]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Hepatocellular carcinoma|Hepatocellular carcinoma (HCC)]]
| |
| |-
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Periampullary adenocarcinoma]]
| |
| |-
| |
| | colspan="4" class="neoplasm-sub" | '''Pancreatic cancer'''
| |
| |-
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Pancreatic cancer|Pancreatic adenocarcinoma, NOS]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Pancreatic cancer, BRCA-mutated|BRCA-mutated Pancreatic adenocarcinoma]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Pancreatic cancer, NRG1-positive|NRG1-positive Pancreatic adenocarcinoma]]
| |
| | class="neoplasm-cell neoplasm-cell--w25" | [[Pancreatic NET]]
| |
| |-
| |
| |}
| |
| | |
| <div class="neoplasm-center neoplasm-footer-link">'''[[Special:AllPages|Browse our complete index of pages]]'''</div>
| |
| | |
| ==Additional Information==
| |
| Created as a knowledge base for hematology & oncology providers, HemOnc.org is a collaborative wiki containing details about hundreds of hematology/oncology drugs, and thousands of treatment regimens. Content is added by hematology & oncology professionals, and undergoes [[how to contribute|continuous peer review]].
| |
| | |
| Any information that one feels would be helpful to other oncology providers is welcome. Visit [[how to contribute]] for more details.
| |
| | |
| Priorities of this project include:
| |
| <section begin=goals />
| |
| *'''Creating a database of all [[Drug index | approved systemic anticancer therapy agents and supportive medications used in the field of hematology/oncology]].
| |
| *'''Creating a database of all standard-of-care systemic anticancer therapy regimens and references to primary literature.
| |
| *'''[[:Category:Example chemotherapy order sets|Sample order sets]] and examples of supportive medications used with treatment regimens
| |
| *'''Aggregating [[External links|useful links]] to existing resources by disease, such as guidelines, information about prognosis, clinical calculators, staging, and patient resources.
| |
| *'''Creating, maintaining, and disseminating a [[Ontology|formalized ontology]] of anticancer drugs and regimens.
| |
| <section end=goals />
| |
| | |
| Additional possibilities for this project may include:
| |
| *Creating synopses of pivotal clinical trials and regimens
| |
| *Prioritizing regimens by their efficacy and/or toxicity
| |
| *Capturing historical regimens that were standard-of-care prior to 2005
| |
| *Checklists for common clinical scenarios/diseases
| |
| *Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects
| |
| | |
| The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as [https://en.wikipedia.org/wiki/Main_Page Wikipedia], will significantly help ease-of-use and navigation.
| |
| | |
| <br><inputbox>
| |
| type=create
| |
| width=70
| |
| placeholder=Type the name of the page you want to create
| |
| break=no
| |
| </inputbox>
| |
